Maxim Group analyst Michael Okunewitch maintained a Hold rating on Gilead Sciences (GILD – Research Report) today. The company’s shares closed ...
In a report released on February 11, Brian Abrahams from RBC Capital maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research ...
Gerdau S/A Ord 1.05% R$34.56B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback